Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,218 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular heterogeneity of triple-negative breast cancer and its clinical implications.
Irshad S, Ellis P, Tutt A. Irshad S, et al. Among authors: ellis p. Curr Opin Oncol. 2011 Nov;23(6):566-77. doi: 10.1097/CCO.0b013e32834bf8ae. Curr Opin Oncol. 2011. PMID: 21986848
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
Irshad S, Gillett C, Pinder SE, A'hern RP, Dowsett M, Ellis IO, Bartlett JM, Bliss JM, Hanby A, Johnston S, Barrett-Lee P, Ellis P, Tutt A. Irshad S, et al. Among authors: ellis io, ellis p. Breast Cancer Res Treat. 2014 Apr;144(2):331-41. doi: 10.1007/s10549-014-2855-4. Epub 2014 Feb 12. Breast Cancer Res Treat. 2014. PMID: 24519386 Clinical Trial.

Tau expression correlated positively with ER (p < 0.001) and PR status (p < 0.001); but negatively with histological grade (p < 0.001) and HER2 status (p < 0.001). ...Tau expression was seen to be a prognostic factor on univariate analysis

Tau expression correlated positively with ER (p < 0.001) and PR status (p < 0.001); but negatively with histological gra

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001).
Hall E, Cameron D, Waters R, Barrett-Lee P, Ellis P, Russell S, Bliss JM, Hopwood P; TACT Trial Investigators. Hall E, et al. Among authors: ellis p. Eur J Cancer. 2014 Sep;50(14):2375-89. doi: 10.1016/j.ejca.2014.06.007. Epub 2014 Jul 24. Eur J Cancer. 2014. PMID: 25065293 Free PMC article. Clinical Trial.
Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
Spicer J, Ellis P. Spicer J, et al. Among authors: ellis p. Cancer Lett. 2007 Apr 18;248(2):165-74. doi: 10.1016/j.canlet.2006.07.002. Epub 2006 Aug 21. Cancer Lett. 2007. PMID: 16919870 Review.
The challenges of integrating molecular imaging into the optimization of cancer therapy.
Patel GS, Kiuchi T, Lawler K, Ofo E, Fruhwirth GO, Kelleher M, Shamil E, Zhang R, Selvin PR, Santis G, Spicer J, Woodman N, Gillett CE, Barber PR, Vojnovic B, Kéri G, Schaeffter T, Goh V, O'Doherty MJ, Ellis PA, Ng T. Patel GS, et al. Among authors: ellis pa. Integr Biol (Camb). 2011 Jun;3(6):603-31. doi: 10.1039/c0ib00131g. Epub 2011 May 4. Integr Biol (Camb). 2011. PMID: 21541433 Review.
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer.
Ellis PA, Saccani-Jotti G, Clarke R, Johnston SR, Anderson E, Howell A, A'Hern R, Salter J, Detre S, Nicholson R, Robertson J, Smith IE, Dowsett M. Ellis PA, et al. Int J Cancer. 1997 Aug 7;72(4):608-13. doi: 10.1002/(sici)1097-0215(19970807)72:4<608::aid-ijc10>3.0.co;2-7. Int J Cancer. 1997. PMID: 9259399 Clinical Trial.
Breast cancer and pregnancy.
Ring AE, Smith IE, Ellis PA. Ring AE, et al. Among authors: ellis pa. Ann Oncol. 2005 Dec;16(12):1855-60. doi: 10.1093/annonc/mdi388. Epub 2005 Jul 19. Ann Oncol. 2005. PMID: 16030024 Review.
Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer.
Archer CD, Parton M, Smith IE, Ellis PA, Salter J, Ashley S, Gui G, Sacks N, Ebbs SR, Allum W, Nasiri N, Dowsett M. Archer CD, et al. Among authors: ellis pa. Br J Cancer. 2003 Sep 15;89(6):1035-41. doi: 10.1038/sj.bjc.6601173. Br J Cancer. 2003. PMID: 12966422 Free PMC article.
Prechemotherapy there was a significant correlation between Ki67 and apoptotic index (AI), r=0.6, (P<0.001). A significant rise in AI (P<0.001), and fall in Ki67 (P=0.002) was seen 24 h following chemotherapy. No relationship was seen between pretreatme …
Prechemotherapy there was a significant correlation between Ki67 and apoptotic index (AI), r=0.6, (P<0.001). A significant rise in …
Clinical studies of apoptosis and proliferation in breast cancer.
Dowsett M, Archer C, Assersohn L, Gregory RK, Ellis PA, Salter J, Chang J, Mainwaring P, Boeddinghaus I, Johnston SR, Powles TJ, Smith IE. Dowsett M, et al. Among authors: ellis pa. Endocr Relat Cancer. 1999 Mar;6(1):25-8. doi: 10.1677/erc.0.0060025. Endocr Relat Cancer. 1999. PMID: 10732783 Review.
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy.
Ellis PA, Smith IE, Detre S, Burton SA, Salter J, A'Hern R, Walsh G, Johnston SR, Dowsett M. Ellis PA, et al. Breast Cancer Res Treat. 1998 Mar;48(2):107-16. doi: 10.1023/a:1005933815809. Breast Cancer Res Treat. 1998. PMID: 9596482
1,218 results
Jump to page
Feedback